These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18243794)

  • 1. Reprogramming the cell cycle machinery to treat cardiovascular disease.
    Bicknell KA; Brooks G
    Curr Opin Pharmacol; 2008 Apr; 8(2):193-201. PubMed ID: 18243794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cell cycle machinery for the treatment of cardiovascular disease.
    Bicknell KA; Surry EL; Brooks G
    J Pharm Pharmacol; 2003 May; 55(5):571-91. PubMed ID: 12831500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventing restenosis after angioplasty: a multistage approach.
    Zargham R
    Clin Sci (Lond); 2008 Feb; 114(4):257-64. PubMed ID: 18194134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
    Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin A: a drug for prevention of restenosis/reocclusion after percutaneous coronary intervention?
    Gidlöf AC; Ocaya P; Krivospitskaya O; Sirsjö A
    Clin Sci (Lond); 2008 Jan; 114(1):19-25. PubMed ID: 18047466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.
    Tejada JG; Velazquez M; Hernandez F; Albarran A; Gomez I; Rodriguez S; Andreu J; Tascon J
    Int J Cardiol; 2009 May; 134(2):201-6. PubMed ID: 18508141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the cardiomyocyte cell cycle be reprogrammed?
    Bicknell KA; Coxon CH; Brooks G
    J Mol Cell Cardiol; 2007 Apr; 42(4):706-21. PubMed ID: 17362983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowing the gap: early and intermediate outcomes after percutaneous coronary intervention and coronary artery bypass graft procedures in California, 1997 to 2006.
    Carey JS; Danielsen B; Milliken J; Li Z; Stabile BE
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1100-7. PubMed ID: 19837215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents 70 restenotic cases from a cohort of 718 patients: FAILS (Failure in Left Main Study).
    Sheiban I; Sillano D; Biondi-Zoccai G; Chieffo A; Colombo A; Vecchio S; Margheri M; Gunn JP; Raina T; Liistro F; Bolognese L; Lee MS; Tobis J; Moretti C
    J Am Coll Cardiol; 2009 Sep; 54(13):1131-6. PubMed ID: 19761932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of drug-eluting stents in venous coronary artery bypass grafts.
    Hernandez-Antolín R; Alfonso F; Jimenez P
    EuroIntervention; 2009 May; 5 Suppl D():D51-7. PubMed ID: 19736072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery restenosis: a paradigm of current treatment approaches.
    Kiernan TJ; Kiernan GD; Yan BD
    Minerva Cardioangiol; 2009 Feb; 57(1):77-94. PubMed ID: 19202520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving long-term outcomes following coronary artery bypass graft or percutaneous coronary revascularisation: results from a large, population-based cohort with first intervention 1995-2004.
    Blackledge HM; Squire IB
    Heart; 2009 Feb; 95(4):304-11. PubMed ID: 19001000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous coronary intervention or coronary artery bypass graft for unprotected left main coronary artery disease: the endless debate.
    Meliga E; Valgimigli M; Buszman P; Serruys PW
    J Am Coll Cardiol; 2008 Aug; 52(7):582-4; author reply 584-6. PubMed ID: 18687257
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac interstitial cells express GATA4 and control dedifferentiation and cell cycle re-entry of adult cardiomyocytes.
    Zaglia T; Dedja A; Candiotto C; Cozzi E; Schiaffino S; Ausoni S
    J Mol Cell Cardiol; 2009 May; 46(5):653-62. PubMed ID: 19162035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.